Extendicare Inc.
EXETF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $440,275 | $383,445 | $374,654 | $391,564 |
| % Growth | 14.8% | 2.3% | -4.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $440,275 | $383,445 | $374,654 | $391,564 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $356,513 | $317,374 | $309,793 | $316,367 |
| SG&A Expenses | $356,513 | $317,374 | $309,793 | $316,367 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $42,909 | $34,766 | $37,528 | $43,995 |
| Operating Expenses | $399,422 | $352,140 | $347,321 | $360,362 |
| Operating Income | $40,853 | $31,305 | $27,333 | $31,202 |
| % Margin | 9.3% | 8.2% | 7.3% | 8% |
| Other Income/Exp. Net | -$6,474 | $10,107 | -$8,414 | -$4,483 |
| Pre-Tax Income | $34,379 | $41,412 | $18,919 | $26,719 |
| Tax Expense | $10,260 | $9,485 | $3,888 | $6,791 |
| Net Income | $24,119 | $31,927 | $15,031 | $19,928 |
| % Margin | 5.5% | 8.3% | 4% | 5.1% |
| EPS | 0.28 | 0.38 | 0.18 | 0.3 |
| % Growth | -26.3% | 111.1% | -40% | – |
| EPS Diluted | 0.28 | 0.37 | 0.18 | 0.28 |
| Weighted Avg Shares Out | 84,628 | 84,463 | 84,444 | 89,276 |
| Weighted Avg Shares Out Dil | 85,833 | 85,595 | 85,403 | 95,248 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,308 | $1,358 | $1,377 | $1,801 |
| Interest Expense | $5,098 | $4,380 | $4,799 | $5,935 |
| Depreciation & Amortization | $9,918 | $8,480 | $8,273 | $8,497 |
| EBITDA | $49,395 | $54,272 | $31,991 | $41,151 |
| % Margin | 11.2% | 14.2% | 8.5% | 10.5% |